Tourmaline Bio, Inc. SC 13G and SC 13G/A reports

Location
27 West 24 Th Street, Suite 702, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Data updated at
11/7/2024, 08:24 AM
Form type Sec Links Description Filing date Reporting date
SC 13G Report Oct 22, 2024
SC 13G Report SC 13G Jun 3, 2024
SC 13G/A Report SC 13G/A 1 TOURMALINE BIO Mar 15, 2024
SC 13G/A Report SC 13G/A Feb 14, 2024
SC 13G Report SC 13G Feb 14, 2024
SC 13G/A Report SC 13G/A Feb 14, 2024
SC 13G/A Report SC 13G/A Feb 14, 2024
SC 13G/A Report SC 13G/A Feb 9, 2024
SC 13G Report SC 13G Feb 9, 2024
SC 13G/A Report Feb 7, 2024
SC 13G Report SC 13G Nov 6, 2023
SC 13G Report Oct 27, 2023
SC 13G Report SC 13G TOURMALINE BIO, INC. Oct 27, 2023
SC 13G Report SC 13G Jul 6, 2023
SC 13G Report NONE Apr 27, 2023
SC 13G Report NONE Apr 27, 2023
SC 13G/A Report SC 13G/A Feb 14, 2023
SC 13G/A Report Aug 9, 2022
SC 13G/A Report SC 13G/A Feb 14, 2022
SC 13G/A Report TALARIS THERAPEUTICS, INC. Feb 14, 2022
SC 13G Report SC 13G Feb 11, 2022
SC 13G Report Feb 4, 2022
SC 13G Report SCHEDULE 13G May 21, 2021
SC 13G Report ACQUISITION OF BENEFICIAL OWNERSHIP May 17, 2021